SAN DIEGO -- A third of breast cancer survivors who received the breast-conserving treatments lumpectomy and radiation rate the appearance of their post-treatment breast as only “fair” or “poor” in comparison to their untreated breast, according to a new University of Pennsylvania School of Medicine study that will be presented today at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO) in San Diego.
Perelman School of Medicine
Arthur Caplan of the School of Medicine comments on medical ethics and medical examiners.
David Grande of the School of Medicine suggests that marketing has a significant impact on doctors and pharmaceutical sales.
PHILADELPHIA - A recently identified immune cell that directs other cells to fight infection plays a critical role in regulating the immune system in both health and disease. Researchers from the University of Pennsylvania School of Medicine have discovered how a stimulatory molecule and a protein found on the membrane of another immune cell make T helper 17 cells multi-taskers of sorts.
John Trojanowski and Jason Karlawish of the School of Medicine discuss research developments.
Healthy sleepers who carry a specific gene variant are more likely to have disrupted sleep, according to University of Pennsylvania study published in the October 26, 2010 issue of Neurology®, the medical journal of the American Academy of Neurology.
SAN DIEGO -- Prostate cancer patients who receive intensity modulated radiation therapy (IMRT) are less apt to suffer serious gastrointestinal complications following their treatment than those who receive three-dimensional conformal radiotherapy (CRT), according to new research from the University of Pennsylvania School of Medicine. The study, which will be presented Nov.